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ABSTRACT
Objective To determine the number of deaths from lung
cancerrelatedtoradoninthehomeandtoexplorethecost
effectiveness of alternative policies to control indoor
radon and their potential to reduce lung cancer mortality.
Design Cost effectiveness analysis.
Setting United Kingdom.
Data sources Epidemiological data on risks from indoor
radon and from smoking, vital statistics on deaths from
lung cancer, survey information on effectiveness and
costs of radon prevention and remediation.
Main outcome measures Estimated number of deaths
from lung cancer related to indoor radon, lifetime risks of
death from lung cancer before and after various potential
interventions to control radon, the cost per quality
adjustedlifeyear(QALY)gainedfromdifferentpoliciesfor
control of radon, and the potential of those policies to
reduce lung cancer mortality.
Results The mean radon concentration in UK homes is 21
becquerels per cubic metre (Bq/m
3). Each year around
1100 deaths from lung cancer (3.3% of all deaths from
lungcancer)arerelatedtoradoninthehome.Over85%of
these arise from radon concentrations below 100 Bq/m
3
andmostarecausedjointlybyradonandactivesmoking.
Current policy requiring basic measures to prevent radon
in new homes in selected areas is highly cost effective,
and such measures would remain cost effective if
extended to the entire UK, with a cost per QALY gained of
£11400 ( €12200; $16913). Current policy identifying
andremediatingexistinghomeswithhighradonlevelsis,
however, neither cost effective (cost per QALY gained
£36800) nor effective in reducing lung cancer mortality.
ConclusionsPoliciesrequiringbasicpreventivemeasures
against radon in all new homes throughout the UK would
be cost effective and could complement existing policies
to reduce smoking. Policies involving remedial work on
existing homes with high radon levels cannot prevent
most radon related deaths, as these are caused by
moderate exposure in many homes. These conclusions
arelikelytoapplytomostdevelopedcountries,manywith
higher mean radon concentrations than the UK.
INTRODUCTION
Lung cancer is the commonest fatal cancer in many
countries;intheUnitedKingdomin2006itaccounted
for 22% of deaths from cancer.
1 Most lung cancers are
caused by cigarette smoking, but another recognised
lung carcinogen
2 is the chemically inert gas radon-222
(half-life four days), a ubiquitous natural air pollutant
arising from radioactive decay of the uranium-238
present throughout the earth’s crust. Outdoor radon
concentrations are usually low, but indoors they are
higher, especially in houses and other small buildings,
and in most countries radon is the largest source of
exposure to natural ionising radiation.
2
If inhaled, solid short lived radon progeny may
depositonthebronchialepitheliumexposingsensitive
cells to α irradiation. Radiobiological evidence sug-
gests that cells exposed to even a single α particle
becomeappreciablydamaged.Therefore,atlowdoses
theriskofcancerisproportionaltothenumberofcells
exposed, and the dose-response relation is likely to be
linear.
3Formostpeoplethebronchialdoseofradiation
isdeterminedprincipallybytheconcentrationofradon
in the home. Studiesof radon relatedlung cancer have
quantified the risk in terms of radon concentration
rather than radiation dose because concentrations can
be measured directly. For the same reason policies to
controlradonareusuallyformulatedintermsofradon
concentration.
The risk from indoor radon used to be estimated
indirectly by extrapolation from risks seen in miners
exposedtoradon.Suchextrapolationshadlimitations,
however, as the miners were exposed under different
conditions,usuallyatmuchhigherconcentrations,and
little information was available on their smoking
histories. Recently, direct evidence has become avail-
able on the risk of lung cancer from indoor radon in
people with well documented smoking histories.
4-6
This clearly confirms a material risk and it enables
thenumberofdeathsfromradonrelatedlungcancerto
be estimated with greater confidence.
Considerable reductions in future radon concentra-
tions in new buildings can usually be obtained at low
cost—for example, by means of a sealed membrane at
ground level, whereas in existing buildings substantial
reductionscanusuallybeachievedatmoderatecost.
7It
is appropriate therefore to consider new buildings and
existing buildings separately when assessing the cost
effectivenessofradoncontrol.Manycountriesalready
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8Theseusuallyfocuson
thesmallproportionofbuildingswhereconcentrations
are above a specified value, typically known as the
“actionlevel”or“referencelevel.”IntheUKtheaction
level for homes is currently 200 becquerels per cubic
metre (Bq/m
3) and current policy is mainly concerned
with identifying existing homes with radon measure-
ments above this level, although in areas with high
radon levels basic preventive measures are also
required for all new homes (table 1).
Previous economic evaluations of indoor radon
9-12
have not made use of the recent direct evidence on the
risk of lung cancer
56 and have not given appropriate
emphasistoprotectioninnewbuildings.Norhavethey
used the cost effectiveness methods now widely
recommended for evaluating health interventions.
13-15
We determined the number of deaths from lung
cancer related to radon in the home and explored the
cost effectiveness of various policies to control indoor
radon and their potential to reduce deaths from lung
cancer in the UK. The methods used are applicable to
other countries, many of which have higher radon
concentrations than the UK.
METHODS
Number of deaths from radon related lung cancer
We obtained the distribution of measured radon
concentrations in UK homes from a nationwide
representative survey.
16 Measured radon varies from
year to year, and we estimated the magnitude of this
variability from studies where measurements were
made in the same home in several different years.
5-18
We obtained the percentage increase in risk of lung
cancer per 100 Bq/m
3 increase in long term average
radon concentration at home from an analysis of data
on radon and smoking histories in more than 7000
peoplewithlungcancerandmorethan21000controls
in nine European countries.
56 The absolute risk of
death from lung cancer in lifelong non-smokers was
taken from a prospective study of more than one
millionAmericansover 20years,
19whichprovidesthe
most reliable risk estimates for this group. The
percentage increase in risk of lung cancer caused by
smoking was taken from a UK study of 1000 people
with lung cancer and more than 3000 controls.
20 From
official statistics we obtained UK population numbers
and numbers of deaths from lung cancer and from all
causes for 2006.
1 Details of the terminology and
methods are given in web extra appendix 1.
Cost effectiveness
The cost effectiveness analysis adhered to the metho-
dologicalframeworkwidelyconsideredappropriatein
economic evaluation of health interventions.
13-15 We
constructed a model to estimate lifetime risk of fatal
lung cancer before and after preventive measures to
reduce radon levels, using the estimated risks of lung
cancer. To obtain quality adjusted life years (QALYs)
wecalculatedlifeyearsgainedandadjustedtheseusing
age specific and sex specific normative weights.
Calculations allowed for the competing risk of death
from other causes. Further details are given in web
extra appendix 2.
We included direct costs incurred or saved by
homeowners, government departments and agencies
including the Health Protection Agency, and the
United Kingdom’s health service. For new homes,
the relevant agencies provided agreed estimates of the
currentcostsofbasicpreventivemeasures.Forexisting
homes,remediationcostsincludedthe costofidentify-
ing homes targeted by policy, and the capital, main-
tenance, running, and replacement costs of remedial
work. We also included treatment costs for patients
with lung cancer, and the healthcare use of patients
duringanyextendedlifeexpectancy.Weassumedthat
initial programme costs, including all measurement
Table 1 |Summary of current government policy on radon in England*
Mean indoor radon concentration in local area† Current policy requirement‡
New homes:
<52 Bq/m
3 (<3% of measurements >200 Bq/m
3)§ None
52-86 Bq/m
3 (3-9% of measurements >200 Bq/m
3) Basic preventive measures, such as a sealed membrane at ground level
Atleast87Bq/m3(≥10%ofmeasurements>200Bq/m
3) “Full preventive measures” consisting of basic preventive measures plus installation of
under-floor ventilation, such as fitting a radon sump and pipe¶
Existing homes:
<64 Bq/m
3 (<5% of measurements >200 Bq/m
3)N o n e
At least 64 Bq/m
3 (≥5% of measurements >200 Bq/m
3) A series of targeted programmes offer free (government funded) measurements to
homeowners on a rolling basis. If measured radon concentration is >200 Bq/m
3,t h e n
homeowners are advised to remediate at their own expense
*Policies in other parts of UK differ slightly. For details see document from Independent Advisory Group on Ionising Radiation.
21
†Such as a 1 km or 5 km grid square, administrative area or division of postcode system.
‡In addition, areas with mean indoor radon concentration more than 36 Bq/m
3 (>1% of measurements >200 Bq/m
3)h a v eb e e nd e s i g n a t e da s“radon
affected” areas. The Health Protection Agency recommends that anyone living in such areas should measure the radon concentration in their home and
remediate if measured radon exceeds 200 Bq/m
3. Employers are required to measure radon concentrations in both new and existing workplaces in
areas designated as radon affected and in underground workplaces in any area, and to restrict exposure if measured radon exceeds 400 Bq/m
3 (www.
hse.gov.uk/radiation/ionising/radon.htm).
§The distribution of indoor radon measurements over different homes in an area is closely approximated by a log normal distribution, and so a
predictable relation exists between mean indoor radon concentration in an area and percentage of measurements above any particular value. (See
web extra appendix 1 for further details.)
¶There is no requirement to measure radon concentrations in these homes after they have been built or to activate the sump—for example, by
installing a fan. Therefore, “full protective measures” currently required do not reduce radon concentrations more than basic preventive measures.
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year. Costs are expressed in 2007 pounds sterling.
Input values used for cost effectiveness analyses are
summarised in web extra appendix 3.
To calculate the cost effectiveness of various inter-
vention programmes compared with no programme
we combined the estimates of effects and costs. Cost
effectivenesswascalculatedastheratioofnetchangein
cost to net change in outcome, with outcome (lung
cancer deaths averted) expressed in terms of life years
gainedandQALYsgained;thisenablescomparisonof
the cost effectiveness of various radon policies with
eachotherandwithotherpublichealthandhealthcare
interventions.
Weevaluatedallpoliciesover100yearstocoverthe
life time of buildings and human lifespan, with costs
discounted to present values at 3.5% per annum and
benefitsat1.5%perannum,inlinewithDepartmentof
Health guidance.
15 Benefits were assumed to occur
evenly over time, with no lag between reduction of
radon levels and starting risk reduction. We examined
the uncertainty around the various assumptions and
data inputs using one way analysis and probabilistic
sensitivity analyses. Additional sensitivity analyses
using radon related risks estimated indirectly from
studies of exposed miners are presented elsewhere.
21
We assessed the value for money of radon inter-
ventionsusingtheapproachadvocatedbytheNational
Institute for Health and Clinical Excellence (NICE) in
England and Wales, where interventions with a cost
effectivenessoflessthan£20000perQALYgainedare
likely to be viewed favourably, whereas those with a
cost per QALY gained of more than £30000 are likely
to be viewed unfavourably.
22 NICE is mainly con-
cernedwiththeNHS,butherethecostsorsavingsalso
fall on other agencies and on households and so are
included. Other ways of valuing health gains in UK
government departments, such as “statistical life”
values to inform decisions on transport safety, or
willingness to pay for improved air quality, also give
valuesperyearoflifeintherange£27500-£35000.
2324
Hence we take the range £20000-£30000 per QALY
gained to indicate likely upper limits to society’s
willingness to pay for health gain, irrespective of who
incurs the costs.
Potential to reduce the number of deaths from lung
cancer
We evaluated the potential of current and possible
future policies to reduce the number of deaths from
lung cancer in the UK population. We calculated the
number of deaths from radon related lung cancer that
would arise if the policy were fully implemented
throughouttheUKandwecomparedthatnumberwith
thecurrentnumber.Detailsofthemethodsaregivenin
web extra appendix 1.
RESULTS
Deaths from radon related lung cancer
ThemeanindoorradonconcentrationinUKhomesis
21 Bq/m
3. In 2006, 3.3% of deaths from lung cancer in
theUK(1in516ofalldeaths)were causedbyradonin
the home. Overall, 48% of radon related deaths
occurred in adults aged 55-74. Most of the remainder
occurred in those aged more than 75, with only 6% at
ages less than 55, and virtually none below age 35 (see
web extra appendix 4). Fifty eight per cent of radon
related deaths were in men.
About 1 in 7 of the deaths from radon related lung
cancer is caused by radon and not by active smoking
(table 2). The remainder are caused jointly by radon
and active smoking as the cancer could have been
prevented by avoiding exposure to either factor. For
lifelong non-smokers living in a home with long term
average radon concentration equal to the UK mean of
21 Bq/m
3, the cumulative risk of death from lung
cancer by age 75 is 0.42% (fig 1). For a hypothetical
radon concentration of zero the value would reduce
slightlyto0.41%,andforhomeswithconcentrationsof
200 Bq/m
3 it would increase to 0.53% and further to
0.66% and 0.92% for lifelong non-smokers living in
homes with concentrations of 400 Bq/m
3 and 800 Bq/
m
3,respectively.Forcigarettesmokers,thecumulative
risk of death from lung cancer by age 75 in the UK
when the indoor radon concentration is equal to the
UK mean is 15%, and increases to 19% for a radon
concentration of 200 Bq/m
3 and to 23% and 31% for
cigarette smokers exposed to concentrations of 400
Bq/m
3 and 800 Bq/m
3, respectively. For former
smokers the risk is substantially lower than for
continuing smokers, even for those stopping as late as
age 50, but it remains considerably above the risk for
lifelong non-smokers (fig 1). Nearly half of the deaths
causedjointlybyradonandactivesmokingoccurredin
former smokers (table 2), a proportion that will rise in
the future if the number of former smokers increases.
If it were possible to measure radon concentrations
in all homes in the UK, an estimated 91% of
measurements would be less than 50 (mean 16) Bq/
Long term average radon (Bq/m3)
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Fig 1 | Cumulative risk of death from lung cancer by age 75
according to long term average radon concentration at home
for current cigarette smokers, former smokers, and lifelong
non-smokers in UK, based on 2006 death rates. The long term
average radon concentration in a home is the value that would
be obtained if the concentration were measured in the home
many times in different years (see also web extra appendix 1)
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3, with 6% in the range 50-99 (68) Bq/m
3, and 2% in
the range 100-199 (133) Bq/m
3. Only an estimated
0.4% of homes in the UK would have measured radon
concentrations 200 (mean 304) Bq/m
3 or higher.
Although people living in such homes have a greater
risk than those living in homes with lower measure-
ments,fewsuchpeopleexist.Theestimatedpercentage
ofdeathsfromradonrelatedlungcancerinhomeswith
measurements of 200 Bq/m
3 or more is 4%, with
measurements of 100-199 Bq/m
3 is 9%, and with
measurements of 50-99 Bq/m
3 is 17%. The remaining
70% of deaths from radon related lung cancer are in
homeswherethemeasurementwouldbebelow50Bq/
m
3 (fig 2). The Health Protection Agency has desig-
nated areas where more than 1% of measurements
exceed 200 Bq/m
3 (that is, mean radon >36 Bq/m
3)a s
“radon affected,”
21 but 75% of radon related lung
cancers arise elsewhere.
Cost effectiveness of policies for new homes
Table 3 reports estimates of cost effectiveness for
installing basic preventive measures to prevent radon
in all new homes during construction in areas where
about 3% of homes have radon measurements above
the current action level of 200 Bq/m
3—that is, areas
where the mean indoor radon concentration is 52 Bq/
m
3.Practicalpoliciestargetareasaboveacertainvalue
ratherthanareasataparticularvalueasinthisexample.
However, it is necessary to calculate cost effectiveness
at particular values to determine where to set policy
thresholds.
The cumulative lifetime risk of death from lung
cancer for a member of the general population falls
from 6.38% at pre-prevention radon concentrations to
6.14%post-prevention,equivalenttoareductionof5.7
deaths per 1000 households of average size (2.4
occupants) who remediate. This is equivalent to 76.2
life years gained, or 31.2 discounted QALYs gained.
The costs per household are the basic preventive
measures of £100 and additional costs to the health
systemof£177fromaddedlifeexpectancy,while£29is
saved from treatment costs for lung cancers averted,
resulting in a net societal cost of £248 per household.
The cost per QALY gained is therefore £7953 (£3201
considering only radon prevention costs and £4752
considering only NHS costs). This is well below the
maximumlevelthatmighttypicallybeconsideredcost
effective (£20000-£30000 per QALY gained).
ThesocietalcostperQALYgainedofinstallingbasic
measures to prevent radon in new homes decreases as
the mean indoor radon concentration in the local area
rises, and increases as the mean radon concentration
falls (table 4). However, even in areas with a mean
radon concentration as low as 10 Bq/m
3, the cost per
QALYgainedisstillonly£21400(£16600considering
preventivemeasuresonlyand£4800consideringNHS
costsonly).WhentheentireUKisconsidered,thecost
per QALY gained is £11400 (£6600 considering
preventive measures only and £4800 considering
NHS costs only). This suggests that a policy of
requiring basic preventive measures in all new homes
throughout the UK would be highly cost effective.
Figure3summarisestheresultsofonewaysensitivity
analyses of varying eight input values for the cost
effectivenessof installing basic preventivemeasures in
allnewhomesthroughouttheUKfromtheirbaselines.
Changes in the cost of treatment for lung cancer, or
introducing a latency period for a reduction in risk of
lungcancer,havelittleeffect.Incontrast,theresultsare
sensitivetothecostandeffectivenessofinstallingbasic
protection measures, to assumptions regarding the
percentage increase in risk of lung cancer per 100 Bq/
m
3, and to the discount rates: at 0% for outcomes and
3.5% for costs, cost effectiveness falls to £6000 per
QALY gained, whereas at a 6% discount rate for both
costs and outcomes, cost effectiveness increases to
£28200 per QALY gained. At discount rates of 3.5%
for costs and outcomes, as recommended by NICE,
22
the cost per QALY gained rises to £16100. Spending
more on basic preventive measures—for example,
using more gas resistant material or having a stricter
inspectionregimen—mightbeworthwhilebutonlyifit
produced a substantial additional reduction in radon
levels (see web extra appendix 6). A probabilistic
sensitivity analysis, in which all variables were varied
simultaneously and independently, showed that a
policy of basic measures in all new homes has
probabilities of being cost effective of 94% and 99%
Table 2 |Numbers of deaths from lung cancer in United Kingdom, 2006, by cause
Cause
No (%) of
deaths from
lung cancer Deaths from lung cancer
Not active smoking or indoor radon 4664* (13.6)
Radon but not active smoking 157† (0.5)
3.3% due to
radon§
86.4% due to
active
smoking or
radon
Active smoking and radon‡:
85.9% due
to active
smoking
Current smokers 532 (1.6)
Former smokers 421 (1.2)
Active smoking but not indoor radon 28 376 (83.1)
Total No of lung cancer deaths¶ 34 150 (100)
*Including any deaths caused by passive smoking but not by radon.
†Including any deaths caused by passive smoking and radon.
‡Cancers that would have been avoided by avoidance of either indoor radon or smoking.
§Mean indoor concentration of radon in UK is 21 Bq/m
3.
¶Total number of deaths from all causes in UK in 2006 was 572 224. Indoor radon is estimated to cause 1110
(that is, 157+532+421) deaths (1 in 516 or 0.2% of deaths from all causes in UK).
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Fig 2 | Distributions of measured radon concentrations in UK
homes and of deaths from radon related lung cancer
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£20000or£30000perQALYgained,respectively(see
web extra appendix 7a).
Cost effectiveness of policies for existing homes
Table 3 also reports cost effectiveness estimates for a
policy targeting existing homes in areas where about
5% have measured radon above 200 Bq/m
3—that is, a
mean indoor radon concentration of 64 Bq/m
3. The
cumulative lifetime risk of death from lung cancer is
7.82%atpre-remediationradonconcentrationsinsuch
areas, falling to 6.19% after remediation. This is
equivalent to a reduction of 39.0 deaths per 1000
households of average size who remediate, which in
turn is equivalent to 516.9 life years gained, or 212.0
discounted QALYs gained.
The mean indoor radon concentration in an area
determines the number of houses that have to be
measured to identify one with concentrations over the
action level. Under current policy, invitations to
measure typically have a 30% acceptance rate, and
recommendations to remediate a 20% uptake.
2526
Therefore in an area with a mean indoor radon
concentration of 64 Bq/m
3—that is, where 5% of
measurements exceed 200 Bq/m
3—333 invitations to
measure would be required to yield 100 homes
measured,fiveabove200Bq/m
3,andoneremediating.
Thesecosts,togetherwithremediationcosts,cometoa
discountedtotalof£6801.Another£1203isincurredin
healthcarecostsduringaddedlifeexpectancy,whereas
£195 is saved from averted treatment costs for lung
cancer. Consequently the net cost is £7809 per house-
hold remediating. The resulting cost per discounted
QALY gained is £36829 (£32077 considering radon
measurement and remediation costs only and £4752
c o n s i d e r i n gN H Sc o s t so n l y ) .T h i si sa b o v et h e
maximum value that is typically considered good
value for money when assessing alternative ways of
improving health.
The cost per QALY gained of remediating existing
homes varies as the mean radon concentration in the
area changes, and for any given mean radon concen-
trationthecostperQALYalsovariesiftheactionlevel
is changed. This is partly because the action level
influences the mean radon concentration in homes
remediating, but also because the action level deter-
mines the number of homes advised to remediate and
thereforeinfluencesthenumberofremediatinghomes
over which the initial detection costs can be spread.
Reducing the current action level to 100 Bq/m
3 might
makeapolicyforexistinghomescosteffectiveforareas
with a mean indoor radon concentration of 60 Bq/m
3.
The cost per QALY would be £29800 compared with
£36800 for the current policy in areas with a mean
radon concentration of 64 Bq/m
3 (table 5).
Figure 3 shows the results of one way sensitivity
analyses on invitations to measure existing homes in
areas with a mean indoor radon concentration of 60
Bq/m
3 and a recommendation to remediate if mea-
suredradonisabovean actionlevelof100 Bq/m
3.I ti s
evident that cost effectiveness is particularly sensitive
to risk of radon related lung cancer and discount rates
andthatitisalsoinfluencedbytheproportionofhomes
over the action level undergoing remediation. At
discount rates of 3.5% for costs and outcomes, as
recommended by NICE,
22 the cost per QALY gained
rises to £36100. A probabilistic sensitivity analysis
showed that this policy has probabilities of being cost
effective of 16% and 54% when decision makers are
prepared to spend up to £20000 and £30000 per
QALY gained, respectively (see web extra appendix
7b).
The health benefits of interventions against radon
vary greatly depending on the number and character-
istics of people in the home. For new homes this has
littlerelevancetopolicy.Forexistinghomes,however,
the relevance may be substantial. Table 6 shows cost
Table 3 |Cost effectiveness of current government policy to control radon in England. Costs are
in pounds sterling
Description New homes*
Existing
homes†
Lifetime cumulative risk of death from lung cancer (% per person)
Pre-preventive action 6.38‡ 7.82§
Post-preventive action 6.14 6.19
Health gain per 1000 households remediating
Lung cancer deaths averted 5.7 39.0
Total life years gained 76.2 516.9
Total life years gained—discounted 39.9 270.8
Total QALYs gained 59.6 404.7
Total QALYs gained—discounted 31.2 212.0
Resource use and costs per household remediating
Radon prevention cost 100 —
No of invitations to measure — 333
Invitation costs — 550
No of radon measurements — 100
Radon measurement cost — 4200
Radon remediation cost¶ — 2051
Subtotal: invitation, measurement, and remediation costs¶ 100 6801
NHS lung cancer treatment costs averted¶ 29 195
Other NHS costs incurred by added life expectancy¶ 177 1203
Net cost¶—societal: 248 7809
To NHS 148 1008
To Health Protection Agency — 4750
To households 100 2051
Cost effectiveness¶ ¶
Cost per life year gained—societal 6226 28 833
Cost per QALY gained—societal: 7953 36 829
To NHS 4752 4752
To homeowners,** and to Health Protection Agency and government
departments††
3201 32 077
£1( €1.1; $1.5). QALY=quality adjusted life year.
*Basic preventive measures in all new homes in areas where 3% of homes have measured radon >200 Bq/m
3
(that is, mean indoor radon 52 Bq/m
3).
†Inviting households in existing homes to measure in areas where 5% of homes have measured radon >200 Bq/
m
3 (that is, mean indoor radon 64 Bq/m
3) and recommending remediation if measurement is above current
action level of 200 Bq/m
3.
‡Lifetime cumulative risk at mean indoor radon 52 Bq/m
3for all homes in area.
§Lifetime cumulative risk at mean indoor radon 308 Bq/m
3 for homes with measurements >200 Bq/m
3.
¶Discounted.
**Radon prevention in new homes, or remediation costs in existing homes.
††Invitation and measurement costs in existing homes.
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areas with a mean indoor radon concentration of 60
Bq/m
3 and with an action level of 100 Bq/m
3 for a
household of average size. The calculation has been
repeated for hypothetical populations consisting
entirelyoflifelongnon-smokersandentirelyofcurrent
cigarettesmokers.Itisevidentthatremediationislikely
tobehighlycosteffectiveforcurrentcigarettesmokers
(<£14000perQALYgained),butverycostineffective
for never smokers (>£173000 per QALY gained). For
former smokers, cost effectiveness will be between the
values for never smokers and current smokers. In
practice, smoking status may be unchanged over long
periods for particular households, but vary for a given
house as ownership changes.
Cost effectiveness of policies for new homes in high radon
areas
In areas where, in the absence of any preventive
measures,atleast10%ofhomeswouldhavemeasured
radonconcentrationsabove200Bq/m
3—thatis,where
the mean radon is at least 87 Bq/m
3, the current policy
for full preventive measuresrequires fitting a means of
under-floor ventilation, such as a sump and associated
pipework,inadditiontobasicpreventivemeasures(see
table 1). This is to facilitate the later installation of
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Fig 3 | Sensitivity of cost effectiveness to changes in input values of installing basic preventive measures in all new homes
throughout UK (top), and of invitations to existing homes to measure and recommendation to remediate for measurements above
an action level of 100 Bq/m
3 in areas with mean indoor radon 60 Bq/m
3 (bottom)
Table 4 |Cost per quality adjusted life year (QALY) gained
(discounted) of requiring basic measures to prevent radon in
new homes by mean indoor radon concentration in area
Mean indoor radon
concentration in local
area (Bq/m3)
Cost (£) per QALY
gained (discounted)
%ofnationalhousing
stock in areas with
mean at or above this
value
10 21 400 87.5
20 13 100 39.6
30 10 300 16.7
36* 9400 10.3
40 8900 7.6
50 8100 3.7
52† 8000 3.2
60 7500 1.9
64‡ 7400 1.5
70 7100 1.0
80 6800 0.6
87§ 6700 0.4
90 6600 0.4
Entire UK:
21 11 400 100
£1( €1.1; $1.5).
*1% of measurements >200 Bq/m
3.
†3% of measurements >200 Bq/m
3, and limit of current policy.
‡5% of measurements >200 Bq/m
3.
§10% of measurements >200 Bq/m
3.
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page 6 of 11 BMJ | ONLINE FIRST | bmj.comactive preventive measures (such as an electric fan) if
the house still has a high radon concentration.
However, as the current policy does not require the
measurement of radon nor installation of active
measures, the effectiveness is similar to the policy for
basic measures although the cost is higher. Therefore
the incremental cost effectiveness of full preventive
measures in such areas compared with the policy for
basic measures is infinite.
A more logical policy for full preventive measures
would require radon to be measured in such houses
after construction and occupation, and the installation
of active measures, such as an electric fan, when
appropriate.Atthecurrentactionlevelforradonof200
Bq/m
3 such a policy would have a cost per QALY
gained of £53500 in areas with a mean radon
concentrationof87Bq/m
3.Thepoorcosteffectiveness
occurs because basic preventive measures will already
havehalvedradonlevels,therebyreducingthenumber
of homes with measurements above any particular
action level and so increasing the cost of detecting
them. The cost of fitting large numbers of sumps and
pipeworktoallhomesinthearea,plusthehighlifetime
costs ofrunningandmaintainingactive measuressuch
aselectricfanswhenrequired,alsoadverselyaffectcost
effectiveness. As with policies for existing homes, cost
effectivenesscouldbeimprovediftheactionlevelwere
reduced to 100 Bq/m
3 or 50 Bq/m
3. At such action
levels the policy would be cost effective just below
£30000 per QALY in areas with a mean radon
concentration 90 Bq/m
3, provided that 100% compli-
ance could be achieved (see web extra appendix 5). If
100% compliance could not be achieved, cost effec-
tivenesswouldbepoorerandthepolicywouldonlybe
cost effective in areas with even higher mean radon
concentration.
An alternative policy might be to install only basic
measures during construction, measure radon in all
homes in specified areas, and then retrofit sumps and
pipework in addition to electric fans in homes still
abovetheactionlevel.Thecostofretrofittingwouldbe
higher than the cost of fitting during construction, but
the work would need to be done in fewer homes.
However, compliance might also fall due to the added
disruption involved. Our calculations suggest that
these factors approximately cancel out, giving this
policy no advantage.
21
Potential for different radon policies to reduce deaths
from lung cancer in the UK
Table 7 summarises the estimated effect of current
radon control policies in averting deaths from lung
cancer in the UK and the effect of adopting cost
effective policies. Ten years of the current policy for
new homes (that is, installing basic measures in areas
with mean indoor radon concentration of at least 52
Bq/m
3)wouldavertonlyfivedeathsperyearacrossthe
entireUKpopulation,increasingby0.5deathsperyear
for each year of the policy. In contrast, the suggested
policy of basic measures in all new homes would avert
44 deaths from lung cancer per year after 10 years of
that policy, and this number would increase by 4.4
deaths per year as the policy continued so that a
cumulative total of nearly 1000 deaths would be
Table 5 |Effect on cost per quality adjusted life year (QALY) gained (discounted) of varying both targeted area and action level,
for policy of inviting existing households in targeted area to measure and advising remediation if measurement is above action
level
Targeted area
(Bq/m3 mean
indoor radon)
Cost (£) per QALY gained (discounted)
Action level (Bq/m3 measured value)
25 Bq/m3 50 Bq/m3 100 Bq/m3 150 Bq/m3 200 Bq/m3 300 Bq/m3 400 Bq/m3
20 85 200 105 600 285 200 744 300 1 682 500 6 271 900 17 840 700
30 60 600 56 900 86 100 159 700 293 800 851 800 2 056 100
36* 53 100 47 200 58 900 93 400 154 700 395 900 885 400
40 49 300 43 000 49 200 71 600 111 500 264 300 564 600
50 42 200 36 200 36 200 44 900 61 200 121 700 233 900
52† 41 000 35 100 34 400 41 600 55 400 106 500 200 200
60 37 200 31 900 29 800 33 400 41 300 70 600 123 300
64‡ 35 600 30 700 28 200 30 700 36 800§ 60 000 101 100
70 33 400 28 900 26 000 27 400 31 500 47 600 76 100
80 30 400 26 600 23 500 23 700 25 900 35 500 52 500
87¶ 28 500 25 200 22 100 21 800 23 200 29 900 42 000
90 27 900 24 700 21 700 21 300 22 400 28 400 39 200
100 25 900 23 200 20 300 19 500 20 100 23 900 31 200
£1( €1.1; $1.5). Calculations carried out for total population and assume that never smokers, current smokers, and former smokers are equally likely to
remediate. See table 6 for separate calculations according to smoking category. Calculations also assume that percentage reduction in radon
concentration that would result from remediation in homes with pre-remediation concentrations of 25 Bq/m
3,5 0B q / m
3,o r1 0 0B q / m
3 would be
similar to that achieved at higher preinstallation concentrations (that is, 85%), although little information is available on this. Entries in bold denote
most cost effective action level for each targeted area. Entries in italics have cost per QALY gained between £20 000 and £30 000.
*1% of measurements >200 Bq/m
3.
†3% of measurements >200 Bq/m
3.
‡5% of measurements >200 Bq/m
3.
§Limit of current policy.
¶10% of measurements >200 Bq/m
3.
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the possible policy for high radon areas, even with
100% compliance, would be to avert only 0.3
additional deaths per year after 10 years, increasing
by0.03deathsperyear,asfewhomeswouldbeaffected
by the policy.
For existing homes, the current policy of targeting
invitations to measure in areas with a mean radon
concentration of 64 Bq/m
3 or above will avert 0.9
deaths from lung cancer per year after the policy has
been fully implemented. Reducing the action level to
100Bq/m
3andwideningthepolicytotargetareaswith
a mean radon concentration of 60 Bq/m
3 and above
would approximately double the number of deaths
averted, to 2.1 per year given the current acceptance
andremediationrates.Iftheseratescouldbeincreased,
sayto60%ofhouseholdsacceptingameasurementand
50% remediating, then the number of deaths averted
would increase to 10.4 per year after full implementa-
tion of the policy.
DISCUSSION
Direct evidence now shows that indoor radon causes
lung cancer in the general population not only at high
concentrations but also at concentrations below 200
Bq/m
3,thecurrentactionlevelforhomesintheUnited
Kingdom.
56 We estimate that radon is likely to be a
cause of about 1100 deaths per year in the UK (about
3.3% of deaths from lung cancer, and 0.2% of all
deaths). In most other countries indoor radon con-
centrations are higher than in the UK
2 and the
proportions of deaths attributable to radon are likely
to be correspondingly higher. For the 27 countries of
the European Union, the mean indoor radon concen-
tration is around 55 Bq/m
3, suggesting that around 8%
of deaths from lung cancer or 18000 deaths each year
are attributable to radon. Indoor radon is therefore a
substantial public health issue. In most countries the
distribution of indoor radon concentrations is highly
skewed,withasmallproportionofhomeshavingmuch
higher concentrations than the mean. Policy to date,
both in the UK and elsewhere, has usually focused on
these high concentrations.
827 As a result, most radon
related lung cancers, which are caused chiefly by the
lower radon levels experienced by most of the
population, have not been addressed.
Policy implications of results
Radon gas is a health hazard that can be reduced by
intervention. It is therefore appropriate to evaluate
policies to control radon using the methods now
routinely used to evaluate other health interventions.
Our results indicate that current government policy in
England of requiring basic preventive measures in all
new homes where the mean radon concentration is at
least 52 Bq/m
3 is highly cost effective compared with
typical maximum values usually considered cost
effective in other public health and healthcare inter-
ventions. Furthermore, such a policy could be
extended to all areas of the UK and still remain well
within the maximum value generally regarded as cost
effective. In south west England, where preventive
measures in new homes are already required, the
material and labour costs involved may have fallen
overtime,anditislikelythatpreventivemeasuresalso
reduce exposure to damp and mould, providing
additional health and economic benefits.
28 Both of
these factors would further improve the cost effective-
ness of basic measures to prevent radon. It would
therefore be appropriate for a policy of basic pre-
ventive measures against radon in all new homes to be
incorporated into the UK building regulations, which
are due to be reconsidered shortly.
29
The current policy of full preventive measures for
new homes in high radon areas in England (table 1)
does not reduce radon concentrations more than basic
measures alone, despite incurring some additional
costs.Itsincrementalcosteffectivenesscomparedwith
basic measures is therefore infinite. An alternative
policy for high radon areas that also required a radon
measurement and installation of active measures such
asanelectricfaninhomeswherethemeasurementwas
above a certain level would, in principle, be more
appropriate. However, even if active measures could
be installed in 100% of the relevant homes, such a
policywouldhavecosteffectivenessbelow£30000per
QALY only in areas where the mean radon
Table 6 |Cost effectiveness of remediating existing homes for total population and for
households consisting entirely of never smokers or entirely of current cigarette smokers,
based on inviting existing households in areas with a mean indoor radon concentration of 60
Bq/m
3 to measure, and remediation advised if measurement is above an action level of 100
Bq/m
3. Costs are in pounds sterling
Description Total population*
Never smokers only
in household†
Current cigarette
smokers only in
household‡
Lifetime cumulative risk of death from lung cancer (% per person)
Pre-remediation 7.13 0.94 28.52
Post-remediation 6.09 0.80 24.81
Health gain per 1000 households remediating
Lung cancer cases averted 25.1 3.4 89.2
Total QALYs gained§ 136.3 20.2 352.3
Resource use and costs per household remediating§ §
Invitation, measurement, and
remediation costs
3414 3414 3414
NHS lung cancer treatment costs
averted
126 17 447
OtherNHScostsincurredbyaddedlife
expectancy
774 110 1870
Net cost—societal 4062 3506 4836
Cost effectiveness§ §
Cost per QALY gained—societal: 29 789 173 720 13 727
To NHS 4752 4590 4037
To homeowners, Health Protection
Agency, and government departments
25 037 169 130 9690
QALY=quality adjusted life year.
*Calculated using age specific and sex specific lung cancer death rates for entire UK population.
†Calculated using age specific and sex specific lung cancer death rates for a population of lifelong non-
smokers.
19
‡Calculated using age specific and sex specific deaths from lung cancer for current cigarette smokers in UK.
Rates were derived from observed age specific and sex specific lung cancer death rates for 2006 for the total UK
population, estimates of lung cancer death rates for lifelong non-smokers,
19 estimates of relative risks for UK
men with differing smoking habits compared with continuing cigarette smokers,
20 and estimates of proportion
of population according to smoking status for categories of age and sex.
21 31
§Discounted.
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tive measures was above about 90 Bq/m
3. If the
distribution of radon concentrations in new homes in
the UK is similar to that of existing homes, this would
apply to only about 0.4% of new homes (table 4).
Thereforeitisnotsurprisingthatitspotentialtoreduce
lung cancer mortality is limited (table 7).
For existing homes, current government policy for
England has cost effectiveness above the maximum
value usually accepted in other public health and
healthcare interventions. Lowering the action level
from its current value of 200 Bq/m
3 to 100 Bq/m
3
would improve cost effectiveness and might bring it
down to just below £30000 per QALY in areas with a
meanindoorradonconcentrationof60Bq/m
3(table 5).
There would be a further improvement in cost
effectiveness if the proportion of households carrying
out remediation when the measured radon exceeded
the action level (to date around 20%
26) could be
increased(fig3).Thismightbeachievedthroughbetter
advice and support to homeowners who have been
recommended to remediate. Other methods, such as
requiring homeowners throughout the country to
disclose all radon measurements to potential purcha-
sers when selling the home, might also increase
remediation rates.
At present, public funding is available for radon
measurement and mapping, but remediation is at the
homeowner’s own expense. Recent survey data
indicate that the most common reason given for not
remediating after being advised to do so is the likely
cost.
21 Grants towards remediation, similar to insula-
tionschemesordisabilityadaptations,wouldprobably
resultinhigherremediationratesandmightbejustified
on the grounds that radon remediation has health
benefits to future as well as current home occupiers.
Against this, however, a documented low radon
concentration might be favourably reflected in the
house price and so materially benefit homeowners,
especially in high radon areas.
Strengths and limitations of study
Our methods for evaluating cost effectiveness diverge
in some important respects from those currently used
by agencies such as NICE, which is primarily
concerned only with healthcare costs directly attribu-
table to an intervention of interest. Here it was
necessary to include direct costs incurred by home-
owners, who typically bear the cost of taking remedial
action, as well as those of other local and central
government departments involved in radon preven-
tion and remediation, and of builders. As NICE
becomes increasingly involved in issuing guidance on
public health programmes and interventions,
30 this
wider societal perspective may become more com-
mon.
About six in seven deaths from radon related lung
cancer are caused jointly by radon and active smoking
(table 2). The analyses presented here assume that
thosein whomlungcancer isavertedby preventionor
remediation have smoking habits, and therefore lung
cancer risks, typical of the total population. This is
likely to be the case for prevention in new homes. For
existinghomes,however,arecentstudyhasshownthat
remediation rates among homeowners who are life-
long non-smokers are about twice those of home-
owners who are current smokers.
21 This suggests that
the cost effectiveness of remediation in existing homes
may in practice be even less favourable than indicated
by our analyses, possibly by a substantial amount.
Future changes in the prevalence of smoking, or in the
average size of households, would also affect our cost
effectiveness estimates. Our estimates might also be
affected if housing type and smoking habits were
Table 7 |Total numbers of deaths from lung cancer that would be averted by various radon
policies if they were implemented throughout UK
Policy
Total No of lung cancer
deaths potentially averted
every year*
New homes, assuming 200 000 built each year
Current government policy in England: installation of basic radon preventive
measures in areas with mean indoor radon concentration 52 Bq/m
3 or higher†:
By 1 year of policy 0.5
By 2 years of policy 2×0.5
Total by 10 years of policy 5, increasing
by 0.5 each year
Basic radon preventive measures throughout UK:
By 1 year of policy 4.4
By 2 years of policy 2×4.4
Total by 10 years of policy 44, increasing
by 4.4 each year
Possible policy for high radon areas, requiring basic preventive measures plus
fittingameansofunder-floorventilationsuchasaradonsumpandpipe,together
with measurement of radon level after occupation and installation of fan when
measurement exceeds action level‡:
By 1 year of policy 0.03
By 2 years of policy 2×0.03
Total by 10 years of policy 0.3, increasing
by 0.03 each year
Existing homes
Current government policy in England: targeting invitations to measure in areas
with mean radon concentration 64 Bq/m
3 or higher§ and recommending
remediationwhenmeasurement>200Bq/m
3,assuming30%acceptancerateand
20% remediation rate:
After policy fully implemented¶ 0.9
Effect of targeting invitations to measure in areas with mean indoor radon
concentration 60 Bq/m
3 or higher and recommending remediation when
measurement>100Bq/m
3, assuming30% acceptancerateand 20% remediation
rate:
After policy fully implemented 2.1
Effect of targeting invitations to measure in areas with mean indoor radon
concentration60Bq/m
3andrecommendingremediationwhenmeasurement>100
Bq/m
3,butwithacceptancerateincreasedfrom30%to60%andremediationrate
increased from 20% to 50%:
After policy fully implemented 10.4
*Installing radon preventive measures in new homes or reducing radon concentration in existing homes will
avert radon induced lung cancers in every subsequent year.
†At least 3.0% of homes with measurements >200 Bq/m
3. Current government policy in England also requires
provision for under-floor ventilation, such as a sump, in homes in areas with mean indoor radon concentration
87 Bq/m
3 or higher (that is, at least 10% of measurements >200 Bq/m
3). At present there is no requirement
either to measure the subsequent radon concentration or to activate the extra measures. Therefore such a policy
has effectiveness similar to installation of basic measures only, but it has a higher cost. It is therefore not cost
effective compared with a policy of requiring only basic preventive measures.
‡Results shown for areas with a mean radon concentration of 90 Bq/m
3 or higher, an action level of 100 Bq/m
3,
and assuming 100% compliance. Lung cancers averted are additional to those averted by basic radon
preventive measures.
§At least 5% of homes with measurements >200 Bq/m
3.
¶That is, measurement offered in all areas to be targeted and all remediation carried out.
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that may have lower average radon levels. At present
insufficient information is available on this.
Ouranalysesconsiderdeathsonlyfromlungcancer,
and so do not capture the quality of life loss and costs
associated with non-fatal lung cancers. Current five
yearsurvivalfromlungcancerinEnglandisabout7%,
andsothiseffectisunlikelytobelarge,butfuturework
could incorporate non-fatal lung cancers in the
analyses.
Wehaveconsideredonlyradonlevelsathome.This
is partly because radon concentrations are usually
higherinsmallbuildings,suchashouses,thaninlarger
ones, and because most people spend more time at
home than in any other building. However, as the
installationofbasicpreventivemeasuresinnewhomes
is highly cost effective, it is likely that installation of
basicmeasurestopreventradonwouldbecosteffective
inothernewbuildings,suchasschoolsandworkplaces.
Similarly, policies for radon remediation in other
existing buildings are unlikely to be cost effective
except in areas with high radon levels.
Conclusions and policy recommendations
We conclude that basic preventive measures against
radoninnewhomesislikelytobeahighlycosteffective
public health intervention measure, with the potential
to make a modest but worthwhile contribution to
reducingtheannualnumberofdeathsfromlungcancer
in the UK, alongside existing policies to reduce
smoking. UK radon concentrations are lower than
thoseinmostothercountriesandsosimilarpoliciesare
likely to be even more cost effective elsewhere,
depending on the extent of smoking related lung
cancer. In contrast, the case in the UK for additional
preventivemeasuresinnewhomesinhighradonareas,
or for policies to remediate in existing homes, is at
present less clear and the potential of such policies for
reducingthenumberofdeathsfromradonrelatedlung
cancer is limited.
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